Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Sun Pharma Advanced Research Company Ltd.

GO
Market Cap. ( ₹ in Cr. ) 4382.02 P/BV -12.71 Book Value ( ₹ ) -10.62
52 Week High/Low ( ₹ ) 208/109 FV/ML 1/1 P/E(X) 0.00
Book Closure 30/09/2020 EPS ( ₹ ) 0.00 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23
Months121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARAR
FaceValue1.001.001.00
    
    
INCOME   
Revenue From Operations [Net]71.7775.55238.78
Total Operating Revenues71.7775.55238.78
    
Other Income1.7929.4710.88
Total Revenue73.56105.01249.66
    
EXPENSES   
Cost Of Materials Consumed23.1228.1322.11
Operating And Direct Expenses173.05253.81281.41
Employee Benefit Expenses153.58141.84107.00
Finance Costs9.041.697.63
Depreciation And Amortisation Expenses12.3912.5111.77
Other Expenses45.1553.8742.31
Total Expenses416.34491.85472.24
    
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-342.78-386.83-222.58
    
Profit/Loss Before Tax-342.78-386.83-222.58
    
Tax Expenses-Continued Operations   
Current Tax0.731.630.00
Deferred Tax-1.01-1.250.00
Total Tax Expenses-0.270.380.00
Profit/Loss After Tax And Before ExtraOrdinary Items-342.51-387.21-222.58
    
Profit/Loss From Continuing Operations-342.51-387.21-222.58
    
Profit/Loss For The Period-342.51-387.21-222.58
Consolidated Profit/Loss After MI And Associates-342.51-387.21-222.58
    
OTHER INFORMATION   
    
EARNINGS PER SHARE   
Basic EPS (Rs.)-10.55-11.93-7.82
Diluted EPS (Rs.)-10.55-11.93-7.82
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]71.77
Total Operating Revenues71.77
Other Income1.79
Total Revenue73.56
EXPENSES 
Cost Of Materials Consumed23.12
Operating And Direct Expenses173.05
Employee Benefit Expenses153.58
Finance Costs9.04
Depreciation And Amortisation Expenses12.39
Other Expenses45.15
Total Expenses416.34
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-342.78
Profit/Loss Before Tax-342.78
Tax Expenses-Continued Operations 
Current Tax0.73
Deferred Tax-1.01
Total Tax Expenses-0.27
Profit/Loss After Tax And Before ExtraOrdinary Items-342.51
Profit/Loss From Continuing Operations-342.51
Profit/Loss For The Period-342.51
Consolidated Profit/Loss After MI And Associates-342.51
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-10.55
Diluted EPS (Rs.)-10.55
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remain in investor's account.